If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHgCapital Trust plc Regulatory News (HGT)

Share Price Information for HgCapital Trust plc (HGT)

Share Price is delayed by 15 minutes
Get Live Data
382.00    -5.50 (-1.42%)
Bid:
380.00
Ask:
383.00
Spread: 3.00 (0.789%)
Market Cap: £1.73b
HGT Live PriceLast checked at - London Stock Exchange

Intraday HgCapital Trust plc Share Chart

HGT Half-Year Report

18 Sep 2023 07:00

RNS Number : 6822M
HgCapital Trust PLC
18 September 2023
 

HgCapital Trust plc

INTERIM RESULTS FOR THE PERIOD ENDED 30 JUNE 2023

 

 Resilient NAV performance and continued realisation activity in a challenging macro environment

 

London, 18 September 2023: HgCapital Trust plc ('HGT'), today announces its interim results for the period ended 30 June 2023.

 

HGT provides investors with a listed vehicle to invest in unquoted businesses managed by Hg, Europe's largest investor in software & technology-enabled services businesses.The objective of HGT is to provide shareholders with consistent longterm returns in excess of the FTSE AllShare Index by investing predominantly in unquoted companies where value can be created through strategic and operational change.

Highlights over the first half of 2023 include:

 

¡ Strong portfolio trading continued to be the main driver of performance, contributing to a total return NAV increase of 4.6%, closing the period at 473.1p NAV per share and net assets of £2.2 billion

 

¡ Share price total return of +7.1% over the period, closing at 370.50p per share and a market capitalisation of £1.7 billion

 

¡ Against an uncertain macro environment, Hg maintained a disciplined approach to new investment, deploying £33 million on behalf of HGT, including one new investment and several follow-on investments in the portfolio to finance bolt-on M&A

 

¡ £229 million returned to HGT, including the full realisation of Transporeon

 

¡ Continued and significant long-term NAV outperformance of the FTSE All-Share

 

¡ Performance provided through access to Hg's investments, which would in aggregate represent the second largest and the fastest growing technology firm in Europe[1]

An investment of £1,000 made 20 years ago in HGT would now be worth £24,963, a total return of 2,396%. An equivalent investment in the FTSE All-Share Index would be worth £4,208[2]

Jim Strang, Chairman of HGT, commented:

"Your Company has delivered a resilient performance over the first six months of the year. The portfolio continued to deliver strong underlying performance with sales and EBITDA across the top 20 investments (76% of the portfolio) growing at 29% and 30% respectively. Investment activity was noticeably slower in the first half of 2023 as the Manager took a cautious stance on adding to the portfolio. Conditions for transactions in the second half of the year appear more supportive."

 

 

 

David Toms, Head of Research at Hg, commented:

"Our portfolio continues to be driven by growth from existing customers, itself supported by strong renewal rates, cross and up-sell. We enhance this with consistent M&A, which remains a powerful accelerant of our performance."

 

SUMMARY performance

 

 

31 August 2023

% Total return

30 June 2023

31 December 2022

% Total return

NAV per share

473.3p

+4.7%

473.1p

456.6p

+4.6%

Share price

389.0p

+12.4%

370.5p

350.5p

+7.1%

FTSE All-Share Index

+2.7%

+2.6%

YTD 2023 Movement

H1 2023 Movement

Net Asset Value

£2.2bn

+£77m

£2.2bn

£2.1bn

+£76m

Source: Hg, Factset. All references to total return allow for all historic dividends being reinvestedNote: Hg undertakes full revaluations of the portfolio on a quarterly basis, the next process being 30 September 2023, therefore the movement in unrealised value of the portfolio to the end of August 2023 is attributable to post-period transactions and FX only.

 

Performance overview

Net assets of £2.2 billion, with continued long-term outperformance of the FTSE All-Share over one, three, five, ten and twenty-year periods:

- NAV per share of 473.1p, a total return of +4.6% for the six months to 30 June 2023.

- Share price total return of +7.1% over the year

- Proposed interim dividend of 2.0p per share

Strong double-digit growth from the realised and unrealised portfolio:

- Revenue and EBITDA growth of 29% and 30% respectively across the top 20 investments (76% of the portfolio) over the last twelve months.

- £229 million of cash returned to HGT primarily through the realisation of Transporeon and secondary fund transactions

- Valuation multiple (EV/ LTM EBITDA) of 26.2x and net debt to LTM EBITDA ratio of 7.4x for the top 20 investments (76% of the portfolio)

Continued investment and commitments to drive future value:

- £33 million invested on behalf of HGT into one new platform investment, and several follow-on investments to support the growth of existing portfolio companies

- New commitment of €125 million to Hg Mercury 4. Total outstanding commitments at 30 June 2023 of £1.1 billion (December 2022: £1.2 billion). These will be deployed over the next three to four years

- HGT's strong liquidity position coupled with commitments across the most recent vintage of Hg funds ensure that the company is well-positioned to take advantage of investment opportunities as they arise

Credit facility increase:

- The Board of HGT agreed a c.£60 million increase to the multi-currency revolving credit facility bringing the total facility to £350 million, the full balance of which was available at period-end

POST PERIOD EVENTS

§ NAV of 473.3p at 31 August, YTD performance of 4.7% reflecting post-period transactions and FX movements.

§ Net assets of £2.2 billion at 31 August.

§ Share price of 389.0p at 31 August, YTD performance of +12.4%.

§ Estimated gross proceeds of £55 million from the full exit of Commify, and partial exits of Azets and TeamSystem to be received post period, at an average uplift to carrying value of 39%.

§ New investment of £6m in Nomadia

§ Further €50m commitment to Hg Mercury 4 (€175 million total commitment)

§ Available liquid resources (including the credit facility) post-completion of all announced transactions and the interim dividend payable in October 2023, are £657 million (30% of 31 August pro-forma NAV).

§ Outstanding commitments of £1.1 billion (49% of 31 August pro-forma NAV). We expect these to be drawn down over the next three to four years.

Outlook

Commentary from Hg (the Manager):

 

We believe the combination of the long-term nature of listed private equity investment with the types of business that Hg invests in, and robust double-digit growth in trading, can continue to drive long-term performance

 

§ Against a challenging macro environment, Hg's portfolio has demonstrated resilient performance

 

§ The portfolio companies remain focused on selling business-critical and non-discretionary software and services to their underlying business customers, delivering predictable levels of recurring revenue

 

§ Positive trading outlook underpinned by long-term drivers for workplace automation and digitisation which are set to transform the workplace for professionals for decades to come

 

§ While we continue to screen a number of attractive investment opportunities, we remain cautious given the ongoing macro uncertainty. Bolt-on M&A remains a key focus to deploy capital and create incremental equity value in the portfolio

 

§ During the first half of 2023, we remained focused on returning capital to Hg clients, distributing c.£1 billion of liquidity, including £109 million to HGT. This followed an exceptionally strong 2022, when we returned a total of £4 billion, of which HGT's share was £404 million. Further liquidity events are expected over the next twelve months

 

 

- Ends -

 

The Company's 2023 Interim Report and an animated presentation from Hg to accompany the results are available to view at:  http://www.hgcapitaltrust.com/.

 

 

For further details:

 

HgCapital Trust plc

 

 

 

Laura Dixon

George Crowe

+44 (0) 78 2459 2894

+44 (0) 20 8152 5880

Brunswick

Azadeh Varzi

+44 (0)20 7404 5959

 

About HgCapital Trust plc

 

HgCapital Trust plc is an investment company whose shares are listed on the London Stock Exchange (HGT.L). HGT gives investors exposure, through a liquid vehicle, to a portfolio of high-growth unquoted companies, managed by Hg, an experienced and well-resourced private equity firm with a long-term track record of delivering superior risk-adjusted returns for its investors.

 

For further details, see www.hgcapitaltrust.com and www.hgcapital.com


[1] By Enterprise Value, Source: Hg, Factset

[2] All references to total return allow for all historic dividends being reinvested

Please note: Past performance is not a reliable indicator of future results. The value of shares and the income from them can go down as well as up as a result of market and currency fluctuations and investors may not get back the amount they originally invested.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR EAANXFLSDEFA
Date   Source Headline
18th Sep 20237:00 amRNSHalf-year Report and Dividend Declaration
5th Sep 20238:00 amRNSHg agrees to sale of Commify to ECI Partners
17th Aug 20238:00 amRNSHg agrees to partial sale of TeamSystem
4th Aug 20237:15 amRNSEdison issues review on HG Capital Trust (HGT)
20th Jul 20237:00 amRNSHg announces investment in Nomadia
19th Jun 20237:00 amRNSAzets Group secures investment from PAI to join Hg
18th May 20239:00 amRNSHg announces investment in GTreasury
17th May 20235:21 pmRNSResult of AGM
15th May 20237:00 amRNSQ1 2023 Report to 31 March 2023
12th May 20234:53 pmRNSBlock listing Interim Review
4th Apr 202310:04 amRNSDirector/PDMR Shareholding
3rd Apr 20233:51 pmRNSUpdate on HGT's Commitment to Hg's Saturn 3 Fund
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 202310:35 amRNSDirector/PDMR Shareholding
28th Mar 202312:24 pmRNSDirector/PDMR Shareholding
16th Mar 20232:14 pmRNSHgCapital Trust results summary with Doceo
15th Mar 202310:55 amRNSDirector/PDMR Shareholding
13th Mar 202310:51 amRNSUpdate on Silicon Valley Bank
13th Mar 20237:00 amRNSAnnual Results & Notice of Annual General Meeting
13th Mar 20237:00 amRNSAnnual Financial Report
31st Jan 20234:50 pmRNSBlock listing Interim Review
13th Dec 20227:00 amRNSHg agrees to sale of Transporeon
16th Nov 20227:00 amRNSEdison issues update on HgCapital Trust (HGT)
14th Nov 20227:00 amRNS3rd Quarter Results
1st Nov 202210:10 amRNSTotal Voting Rights
14th Oct 20227:00 amRNSTransaction in Own Shares
5th Oct 20227:00 amRNSIdeagen and ProcessMAP to Combine
4th Oct 20228:25 amRNSTrustQuay Secures Hg Investment
4th Oct 20227:00 amRNSTrustQuay Secures Hg Investment
13th Sep 20227:46 amRNSEdison issues update on HgCapital Trust (HGT)
12th Sep 20227:00 amRNSHgCapital Trust Interim Results 2022
12th Sep 20227:00 amRNSHalf-year Report
2nd Aug 20223:38 pmRNSHolding(s) in Company
20th Jul 20225:50 pmRNSHolding(s) in Company
14th Jul 20221:00 pmRNSHg announces a partial sale of Intelerad
7th Jul 20224:40 pmRNSReplacement: Director/PDMR Shareholding
6th Jul 20227:30 amRNSHg announces further investment in team.blue
5th Jul 20221:43 pmRNSDirector/PDMR Shareholding
4th Jul 20225:18 pmRNSDirector/PDMR Shareholding
28th Jun 20224:00 pmRNSNorstella announces merger agreement with Citeline
24th Jun 20227:00 amRNSHGT Board note agreement on acquisition of Ideagen
14th Jun 20227:00 amRNSHg agrees sale of MEDIFOX DAN to ResMed for US$1bn
9th Jun 20223:56 pmRNSInvestment in TigerRisk Partners
8th Jun 20227:00 amRNSHg further invests in The Access Group
17th May 20226:00 pmRNSHg agrees the sale of itm8 to Axcel
17th May 20227:00 amRNSEdison issues review on HgCapital Trust (HGT)
13th May 20224:54 pmRNSBlock listing Interim Review
10th May 20225:34 pmRNSResult of AGM
9th May 20227:00 amRNS1st Quarter Results
3rd May 20223:23 pmRNSAGM Update - Withdrawal of AGM Resolution

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.